Abortion
Almeida backtracks and denies post-abortion syndrome existence
Iniulat ng AI Larawang ginawa ng AI
Madrid's mayor, José Luis Martínez-Almeida, has backtracked on his stance, now stating that post-abortion syndrome does not exist as a recognized scientific category. This contrasts with support from Spanish bishops and parties like Vox and PP for the concept, despite clear scientific denial. The debate arises amid political discussions on abortion in Spain.
Almeida sees opportunity in plenary to resolve crisis over Vox agreement
Iniulat ng AI
José Luis Martínez-Almeida, Madrid's mayor, views the extraordinary plenary requested by Más Madrid and PSOE as an opportunity to clarify the controversial agreement with Vox on 'post-abortion syndrome'. From Brussels, where he is receiving an award for the Puerta de Alcalá restoration, the mayor admits a communication error that caused confusion. He insists no woman will be forced to receive information on this non-scientific category.
Federal judge blocks expanded access to abortion pill mifepristone
Iniulat ng AI
A federal judge in Texas has issued a ruling limiting the FDA's approval of mifepristone, the primary drug used in medication abortions. The decision revives a long-standing lawsuit challenging the drug's safety and regulatory process. This comes amid ongoing legal battles over abortion access following the Supreme Court's overturning of Roe v. Wade.
Federal judge blocks Idaho abortion ban in emergencies
A federal judge in Idaho has ruled that the state's strict abortion ban cannot be enforced in medical emergencies, providing temporary relief to healthcare providers. The decision addresses concerns that the law endangers women by creating uncertainty in critical situations. This ruling comes amid ongoing legal challenges to post-Roe v. Wade restrictions.
Senator Hawley criticizes FDA approval of new abortion drug
Republican Senator Josh Hawley from Missouri has sharply criticized the Food and Drug Administration for approving a new abortion drug, raising concerns about women's safety and the agency's trustworthiness. In a letter to FDA Commissioner Robert Califf, Hawley accused the agency of prioritizing politics over science. The move highlights ongoing debates over abortion access and regulatory oversight.